ERic Acute StrokE Recanalization (ERASER)
ERASER
1 other identifier
observational
53
2 countries
9
Brief Summary
To monitor the effect of the ERIC® device in combination with SOFIA™ Distal Access Catheter on artery recanalization and on clinical outcomes in stroke patients using data from clinical routine application (ERASER). To additionally evaluate the effect of the ERIC® device in combination with SOFIA™ Distal Access Catheter on the final infarct volume as determined by advanced image postprocessing methods in the subgroup of patients with acute middle cerebral artery stroke (ERASER+).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2015
Typical duration for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
August 25, 2015
CompletedFirst Posted
Study publicly available on registry
August 28, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedOctober 10, 2017
October 1, 2017
1.9 years
August 25, 2015
October 9, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VOST (volume of saved tissue) = VPIv- VMT
volume of saved tissue (VOST) as difference of the brain volume with an infarct risk of \>50%, based on a prediction- algorithm trained in a historical cohort treated with IV tPA (VPIv) and the actual infarct volume
30 h
Secondary Outcomes (2)
mRS≤2
90 days
NIHSS score improvement ≥10 from baseline
90 days
Study Arms (1)
ERIC® and SOFIA™
ERIC® device in combination with SOFIA™ Distal Access Catheter
Interventions
Eligibility Criteria
Patients over 18 year with acute ischemic stroke
You may qualify if:
- Acute ischemic stroke with NIH-SS score of 8-25
- CTP/ MRP \<4.5h after symptom onset completed
- CTA/ MRA confirms M1-occlusion
- Groin puncture estimated \<6h after stroke onset
- Intended usage of ERIC® as first device in combination with SOFIA™ Distal Access -Catheter (secondary bail-out with other devices allowed)
You may not qualify if:
- MCA \>1/3 abnormal in DWI or CBV (ASPECTS ≤ 7, \>100 mL)
- Pre stroke mRS ≥ 2
- Necessity of ipsilateral internal carotid artery (ICA) angioplasty
- Age \<18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Universitätsklinikum Augsburg
Augsburg, Germany
Klinikum Dortmund
Dortmund, Germany
Universität Greifswald
Greifswald, Germany
Asklepios Klinik Altona
Hamburg, Germany
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
Universitätsklinikum Heidelberg
Heidelberg, Germany
Universitätsklinikum Schleswig-Holstein
Lübeck, Germany
Klinikum der Universität München
München, Germany
Kantonspital Aarau
Aarau, Switzerland
Related Publications (1)
Fiehler J, Thomalla G, Bernhardt M, Kniep H, Berlis A, Dorn F, Eckert B, Kemmling A, Langner S, Remonda L, Reith W, Rohde S, Mohlenbruch M, Bendszus M, Forkert ND, Gellissen S. ERASER. Stroke. 2019 May;50(5):1275-1278. doi: 10.1161/STROKEAHA.119.024858.
PMID: 31009356DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jens Fiehler, MD,PhD
Universitätsklinikum Hamburg-Eppendorf
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2015
First Posted
August 28, 2015
Study Start
May 1, 2015
Primary Completion
April 1, 2017
Study Completion
July 1, 2017
Last Updated
October 10, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will not share